Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits-Reference-Cited by-同舟云学术

Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits

Published:2018-04-09 Issue:3 Volume:8 Page:461-472
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Burgalassi Susi,Monti Daniela^ORCID,Nicosia Nadia,Tampucci Silvia,Terreni Eleonora,Vento Andrea,Chetoni Patrizia

Funder

University of Pisa

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/article/10.1007/s13346-018-0520-x/fulltext.html

Reference42 articles.

1. Agarwal A, Rhoades WR, Hanout M, Soliman MK, Sarwar S, Sadiq MA, et al. Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development. Clin Ophthalmol. 2015; https://doi.org/10.2147/OPTH.S74959 .

2. World Health Organization. Action plan for the prevention of avoidable blindness and visual impairment 2009-2013, vol. 2010. Geneva: WHO Document Production Services.

3. Thrimawithana TR, Young S, Bunt CR, Green C, Alany RG. Drug delivery to the posterior segment of the eye. Drug Discov Today. 2011;16:270–7. https://doi.org/10.1016/j.drudis.2010.12.004 .

4. Joseph M, Trinh HM, Cholkar K, Pal D, Mitra AK. Recent perspectives on the delivery of biologics to back of the eye. Expert Opin Drug Deliv. 2016;14:631–45. https://doi.org/10.1080/17425247.2016.1227783 .

5. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007;114:855–9. https://doi.org/10.1016/j.ophtha.2007.01.017 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02

2. Experimental and mathematical approaches for drug delivery for the treatment of wet age-related macular degeneration;Journal of Controlled Release;2023-11

3. Ocular Delivery of Therapeutic Proteins: A Review;Pharmaceutics;2023-01-06

4. Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis;Drug Design, Development and Therapy;2022-09

5. Lipid Nanoparticles for the Posterior Eye Segment;Pharmaceutics;2021-12-31